Evidence map›Paper›PMID 34085161›Full record

ArticleInflammation2021

Vanillin Attenuates Cadmium-Induced Lung Injury Through Inhibition of Inflammation and Lung Barrier Dysfunction Through Activating AhR.

Xueshibojie Liu, Jinghui Yang, Jinqiu Li, Chengbi Xu, Wei Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Herbal Medicine, Gut Microbiota, and COVID-19.Frontiers in pharmacology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xueshibojie Liu *Department of Head and Neck Surgery, The Second Affiliated Hospital of Jilin University, Changchun, China.
Jinghui Yang *Department of Hepatobiliary Pancreatic Surgery, China-Japan Friendship Hospital of Jilin University, Changchun, China.
Jinqiu LiDepartment of Head and Neck Surgery, The Second Affiliated Hospital of Jilin University, Changchun, China.
Chengbi XuDepartment of Head and Neck Surgery, The Second Affiliated Hospital of Jilin University, Changchun, China.ORCID http://orcid.org/0000-0002-2316-3211
Wei JiangDepartment of Anesthesiology, The Second Affiliated Hospital of Jilin University, Changchun, China. liuxue123ll@163.com.
Second Affiliated Hospital of Jilin University · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vanillin, the main constituents of vanillin beans, has been reported to exhibit anti-inflammatory effects. However, the effects of vanillin on the cadmium-induced lung injury are still unclear. Therefore, we assay whether vanillin has potential preventive activity on cadmium-induced lung injury in mice. Mice were given vanillin (5, 10, 20 mg/kg) and treated with cadmium for 7 days. The detection data of vanillin on lung tissue changes were analyzed after the cadmium treatment. The results displayed that vanillin obviously decreased the lung histological alterations and myeloperoxidase (MPO) activity. Vanillin also suppressed the levels of TNF-α, IL-1β, and IL-6 in BALF. Furthermore, vanillin prevented cadmium-induced NF-κB activation and upregulation the expression of tight junction protein ZO-1 and occludin. In addition, vanillin significantly increased the expression of aryl hydrocarbon receptor (AhR), and inhibition of AhR by its agonist could reverse the protective effects of vanillin on cadmium-induced lung injury. To sum up, vanillin could be a potential drug for the treatment of cadmium-induced lung injury.

Indexed as

AnimalsAnti-Inflammatory AgentsBasic Helix-Loop-Helix ProteinsBenzaldehydesCadmium ChlorideCytokinesDisease Models, AnimalInflammation MediatorsLungLung InjuryMaleMiceMice, Inbred BALB CNF-kappa BOccludinPeroxidaseAhr protein, mouseAnti-Inflammatory AgentsBasic Helix-Loop-Helix ProteinsBenzaldehydesCadmium ChlorideCytokinesInflammation MediatorsNF-kappa BOccludinOcln protein, mousePeroxidaseReceptors, Aryl HydrocarbonTjp1 protein, mousevanillinZonula Occludens-1 ProteinAhRcadmiumlung injuryNF-κBvanillin

Identifiers

PMID34085161
OpenAlexW3164738379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.